Zydus gets Mexican regulator nod to conduct clinical trials...

Ahmedabad (Gujarat) [India], July 17 (ANI): Pharmaceutical major Zydus said on Friday it has got approval from...

DCGI gives market approval for Pneumococcal Polysaccharide...

New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has given approval to the first...

DCGI approves Itolizumab injection for restricted emergency...

New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to...

Mylan gets DCGI nod for remdesivir in India, to launch at Rs...

Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir...

DCGI permits human clinical trials for COVID-19 vaccine of...

New Delhi [India], July 3 (ANI): The Drug Controller General of India (DCGI) on Thursday granted permission to...

DCGI gives nod to Mylan labs to manufacture remdesivir for...

New Delhi [India], July 2 (ANI): The Drug Controller General of India (DCGI) has granted permission to Mylan...

DCGI gives nod to Bharat Biotech to conduct phase I & II...

New Delhi [India], June 30 (ANI): The Drug Controller General of India (DCGI) has granted permission to Bharat...

Anti-viral drug favipiravir gets DGCI nod for 'restricted...

New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral...

COVID-19: Pharma giants seek DCGI's approval to manufacture,...

New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached...

Zydus Cadila approaches DCGI to use hepatitis drug for...

New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has...

Glenmark to conduct clinical trials on Favipiravir anti-viral...

Mumbai (Maharashtra) [India], April 30 (ANI): Glenmark Pharmaceuticals said on Thursday it has received approval...

DCGI permits import of drug with residual shelf life less...

New Delhi [India], April 18 (ANI): In view of the COVID-19 pandemic, the country's top drug controller has granted...